AVIR

Atea Pharmaceuticals, Inc.

Halal Rating :
Questionable
See Details
Last Price $4.45 Last updated:
Market Cap $362.95m
7D Change 3.8%
1 Year Change 23.45%

Company Overview

Industries
  • Health Technology
  • Pharmaceuticals: Major
Exchange NASDAQ
Next Earnings Date Nov. 6, 2023

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapies for patients suffering from viral infections. The company is headquartered in Boston, Massachusetts.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2023 $4.32m $57.71m $7.86m $4.32m 182.16% 7.48%
June 30, 2023 $3.7m $52.1m $7.3m $3.7m 197.54% 7.10%

Company Impact

Help us evaluate Atea Pharmaceuticals, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates